Refractory Multiple Myeloma - Pipeline Review, H1 Market 2014: Global Industry Emerging Opportunities, Trends, Size, Drivers, Strategies, Products and Competitive Landscape
This report provides comprehensive information on the therapeutic development for Refractory Multiple Myeloma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Refractory Multiple Myeloma and special features on late-stage and discontinued projects.
View full press release